RxDoctor Payments DataLook up a doctor →

Molecular Genetic Pathology: industry payments

Drug and device makers reported $3,801,583 in payments to providers registered in this specialty across Open Payments program years 20192025.

Providers
90
Received a payment
88 (97.8%)
Total reported
$3.8M
Average, those paid
$43,200

The average is computed only over providers who received something, because including the 2 who received nothing would produce a number that describes neither group. Totals are dominated by a small number of large royalty and consulting arrangements; the typical payment in this specialty is far smaller than the average implies.

By state

StateProvidersTotal reportedPer provider
Washington4$1,820,500$455,125
Massachusetts3$712,682$237,561
Ohio7$358,317$51,188
New York10$197,590$19,759
Missouri4$191,689$47,922
South Carolina2$173,445$86,722
Maryland3$110,600$36,867
Oregon2$62,930$31,465
Vermont1$51,283$51,283
Arkansas3$43,574$14,525
Colorado2$23,362$11,681
Texas5$14,671$2,934
Florida4$13,936$3,484
California13$12,784$983
Minnesota6$5,929$988
Tennessee3$3,284$1,095
North Carolina3$1,611$537
Utah3$1,498$499
Illinois3$781$260
Louisiana1$271$271
Oklahoma1$256$256
Iowa1$200$200
Pennsylvania3$161$54
District of Columbia1$105$105
Georgia1$91$91
Connecticut1$34$34